We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
225 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 20/10 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 10/5 mg modified release tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 40/20 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 5/2.5 mg modified release tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MPL- OXYCODONE/NALOXONE oxycodone hydrochloride / naloxone hydrochloride 60/30 mg modified release tablet blister pack.
-
Australian public assessment report (AusPar)AusPAR for Eligard (Leuprorelin acetate) for the treatment of children with central precocious puberty (CPP).
-
Cancellation by sponsorRequested by Mundipharma Pty Ltd
-
Cancellation by sponsorRequested by Mundipharma Pty Ltd
-
Cancellation by sponsorRequested by Mundipharma Pty Ltd
-
Cancellation by sponsorRequested by Mundipharma Pty Ltd